New patch aims to stop bleeding faster in keyhole surgery

NCT ID NCT05900037

Completed Disease control Sponsor: GATT Technologies BV Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tested a new device called GATT-Patch, a flexible, resorbable patch that helps stop bleeding during minimally invasive (keyhole) liver and gallbladder surgeries. 53 adults were randomly assigned to receive either GATT-Patch or a standard surgical patch. The main goal was to see if GATT-Patch could stop bleeding within 7 minutes without rebleeding. The study is complete, but results are not yet available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: GATT-Patch (a resorbable sealing patch made from porcine gelatin and a polymer coating)
What this could lead to: If it works, this could give surgeons a better tool to quickly stop bleeding during keyhole liver and gallbladder surgeries.
What could go wrong: This is a small, early-stage trial with only 53 participants, so results may not apply to everyone. The patch may not work better than existing options.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GALLBLADDER DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Blood Loss, Surgical gallbladder disorder liver disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GALLBLADDER DISEASES HEMORRHAGE, SURGICAL INTRAOPERATIVE BLEEDING LIVER DISEASES

Contacts and locations

Locations

Atrium Health

Charlotte, North Carolina, 28204, United States
Capital Health

Pennington, New Jersey, 08534, United States
Intermountain Healthcare

Murray, Utah, 84111, United States
University of Southern California

Los Angeles, California, 90033, United States
Washington University

St Louis, Missouri, 63110, United States
Weill-Cornell

New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.